By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Psyadon Pharmaceuticals, Inc. 

2330 West Joppa Road
Suite 355
Lutherville  Maryland  21093  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Psyadon Pharmaceuticals, Inc. Announces The Opening Of A New Clinical Trial Of Ecopipam For The Treatment Of Tourette’s Syndrome In Children Ages 7-17 5/28/2014 8:58:17 AM
Psyadon Pharmaceuticals, Inc. Announces Positive Interim Analysis of Phase 2 Study of Ecopipam for the Treatment of Tourette Syndrome 7/24/2012 10:19:15 AM
Tourette Syndrome Association and Psyadon Pharmaceuticals, Inc. to Collaborate on a Drug Trial for Tourette Syndrome Treatment 5/11/2011 6:35:47 AM
Psyadon Pharmaceuticals, Inc. Announces Dr. William Nyhan’s Participation in the Clinical Trial of Ecopipam in Lesch-Nyhan Disease 6/9/2010 9:51:12 AM
Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease 2/9/2010 9:37:46 AM
Psyadon Pharmaceuticals, Inc. Announces $8M Series A-1 Financing and In-License of Ecopipam from Schering Corporation 11/10/2008 7:18:07 AM
//-->